Proteomics

Dataset Information

0

Characterization of spatial heterogeneity in metastasized colorectal cancer by MALDI imaging


ABSTRACT: About 50% of colorectal cancer patients develop liver metastases. Patients with metastatic colorectal cancer have 5-year survival rates below 20% despite new therapeutic regimens. Tumor heterogeneity has been linked with poor clinical outcome, but was so far mainly studied via bulk genomic analyses. In this study we performed spatial proteomics via MALDI mass spectrometry imaging on six patient matched CRC primary tumor and liver metastases to characterize interpatient, intertumor and intratumor hetereogeneity. We found several peptide features that were enriched in vital tumor areas of primary tumors and liver metastasis and tentatively derived from tumor cell specific proteins such as annexin A4 and prelamin A/C. Liver metastases of colorectal cancer showed higher heterogeneity between patients than primary tumors while within patients both entities show similar intratumor heterogeneity sometimes organized in zonal pattern. Together our findings give new insights into the spatial proteomic heterogeneity of primary CRC and patient matched liver metastases.

INSTRUMENT(S): 4800 Plus MALDI TOF/TOF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Liver, Colon

DISEASE(S): Colon Cancer

SUBMITTER: Lennart Moritz  

LAB HEAD: Melanie Föll

PROVIDER: PXD039409 | Pride | 2023-02-17

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MET_1.TIF Other
MET_1.hdr Other
MET_1.img Other
MET_1.t2m Other
MET_2.JPG Other
Items per page:
1 - 5 of 50

Similar Datasets

2021-06-04 | PXD026459 | Pride
2022-06-10 | PXD034174 | Pride
2014-11-19 | PXD001283 | Pride
2024-07-02 | PXD045377 | Pride
2022-02-15 | PXD019653 | Pride
2022-02-17 | PXD025594 | Pride
2016-07-11 | GSE63490 | GEO
2021-09-10 | PXD023663 | Pride
2023-10-10 | PXD039398 | Pride
2022-10-13 | PXD034851 | Pride